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ABSTRACT 
Matrix-assisted laser desorption/ionization (MALDI) is a key ionization technique in mass 
spectrometry (MS) for the analysis of labile macromolecules.  An important area of study and 
improvements in relation to MALDI and its application in high-sensitivity MS is that of matrix 
design and sample preparation.  Recently, 4-chloro-α-cyanocinnamic acid (ClCCA) has been 
introduced as a new rationally designed matrix and reported to provide an improved analytical 
performance as demonstrated by an increase in sequence coverage of protein digests obtained by 
peptide mass mapping (PMM) (Jaskolla, T. W et al. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 
12200-12205).  This new matrix shows the potential to be a superior alternative to the commonly 
used and highly successful α-cyano-4-hydroxycinnamic acid (CHCA).  We have taken this 
design one step further by developing and optimizing an ionic liquid matrix (ILM) and liquid 
support matrix (LSM) using ClCCA as the principle chromophore and MALDI matrix 
compound.  These new liquid matrices possess greater sample homogeneity and a simpler 
morphology.  The data obtained from our studies show improved sequence coverage for BSA 
digests compared to the traditional CHCA crystalline matrix and for the ClCCA-containing ILM 
a similar performance to the ClCCA crystalline matrix down to 1 fmol of BSA digest prepared in 
a single MALDI sample droplet with current sensitivity levels in the attomole range.  The LSMs 
show a high tolerance to contamination such as ammonium bicarbonate, a commonly used 
buffering agent. 
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INTRODUCTION 
Matrix-assisted laser desorption/ionization
1
 (MALDI) is one of the most commonly used 
ionization techniques for the analysis of (bio)molecules by mass spectrometry (MS) and has 
proven extremely useful in fields such as proteomics.
2-4
  The choice of matrix can have a 
profound impact on peak intensities, relative abundance of analyte, fragmentation of the analyte 
and the types of analyte ions detectable.  Considerable research has gone into trying to define 
what makes a suitable matrix for MALDI.  In general, however, the only steadfast rule is that the 
matrix molecules should absorb the laser energy at the laser wavelength used without imparting 
excessive internal energy to the analyte, whilst promoting the desorption/ionization process (with 
ionization occurring by analyte protonation or deprotonation).  Other desirable matrix qualities 
include vacuum-stability, chemical inertness, and being able to generate a homogeneous 
matrix/analyte mix.  In practice, most matrices cannot meet all of the requirements so a 
compromise must be made based on the application.  Whilst advances in the development of 
matrices in tandem with instrumental developments have allowed for an increase in sensitivity 
and general performance of MALDI MS, the gains made in terms of versatility have come 
predominately from the development of more effective matrices and optimisation of the sample 
preparation techniques.
5-8
 
One development that seems particularly promising is the re-introduction of liquid matrices.
3, 9-13
  
Liquid matrices in the form of particle suspensions were first utilised by Tanaka et al
14
 and have 
been reported for use in MALDI as long as MALDI itself.  However, a lack of overall sensitivity 
meant that they lost favour in light of the advances made possible by the highly sensitive solid 
state matrices α-cyano-4-hydroxycinnamic acid (CHCA)6 and 2,5-dihydroxybenzoic acid 
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(DHB)
5
.  Recently, however, new liquid matrices have been introduced which promise to close 
this sensitivity gap.  The liquid matrices essentially come in one of two forms, an ionic liquid 
matrix (ILM) or a liquid support matrix (LSM).  Typically, ionic liquids (ILs) are salts that melt 
below 100°C, are non-explosive, non-flammable, stable below 250°C and possess negligible 
vapour pressure.
15
  ILs suitable for MALDI were first introduced in 2001 by Armstrong et al.
16
  
and are typically created by the dissolution of an acidic MALDI matrix compound such as 
CHCA in the presence of a counter base such as 3-aminoquinoline
13
 (3-AQ) or aniline
16
 in a 
volatile solvent.  Upon fast solvent evaporation a viscous vacuum-stable ILM remains.  LSMs 
can be formed in a similar fashion to ILMs but with the addition of a liquid support such as 
glycerol.
3, 12
  LSMs can also take the form of particle suspensions.
14, 17-19
  However, the 
suspended particles in these matrices add only little if at all to the ionization process while the 
compounds suspended in the presented LSMs promote both desorption and ionization.  
Furthermore, laser energy deposition facilitated by suspended particles is markedly different to 
the energy absorption process provided by individual matrix molecules, i.e. in the case of UV-
MALDI the electronic excitation of the matrix compound’s chromophore. 
Liquid matrices have a number of potential advantages over the commonly used crystalline 
matrices.  They display superior sample homogeneity with a simpler morphology.
16, 20, 21
  The 
liquid nature of these matrices allows for renewal and self-healing of the irradiated sample 
position enabling an extremely stable ion signal production and sample longevity.
22-24
  
Quantification can easily be achieved across a broad abundance range,
25, 26
 and it has been shown 
that this can be performed without the need for an internal standard.
24
  In addition it has also 
been shown that key properties of the matrix environment such as the pH can be tuned through 
the use of additives.
27
  Liquid matrices have been used for the improved analysis of a variety of 
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molecules including peptides,
3, 28
 proteins,
21
 phosphopeptides,
29
 glycopeptides,
30
 
ogliosaccarides,
30, 31
 phospholipids,
32
 and polymers.
16
  Furthermore, liquid matrices have been 
reported to improve the results of peptide mass mapping (PMM), showing an increase in the 
Mascot-generated probability score for protein identification via database searching as well as 
improved protein sequence coverage when compared to crystalline CHCA.
3, 33
 
Recently, 4-chloro-α-cyanocinnamic acid (ClCCA) has been introduced as a new rationally 
designed MALDI matrix compound.
34
  As a crystalline matrix it has been shown to have great 
potential for the analysis of peptides by PMM showing an improvement in sequence coverage 
and sensitivity when compared to CHCA.  This has been attributed to an increase in the number 
of small and/or acidic peptides which is hypothesised to be due to the lower proton affinity of the 
ClCCA matrix as compared to CHCA allowing for a more efficient proton transfer from the 
[ClCCA+H]
+
 matrix ions to the analyte.
34 
We have taken this rational design one step further by developing and optimising two new liquid 
matrices, an ILM using ClCCA as the principle chromophore in combination with 3-AQ and an 
LSM with glycerol as the support.  We have tested these two matrices in terms of their 
characteristics as liquid matrices and found them both to display a high degree of homogeneity 
as well as possessing similar signal stability in comparison to the two analogous matrices using 
CHCA as the principle chromophore.  In addition the sequence coverage obtained using these 
matrices have been compared to their crystalline analogues using a bovine serum albumin tryptic 
digest as a model protein digest to determine as to whether the ClCCA-containing liquid matrices 
would provide a further increase in protein sequence coverage similar to that reported for 
CHCA-based liquid matrices over crystalline CHCA matrices. 
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EXPERIMENTAL 
Materials 
All solvents were purchased from Rathburn (Walkerburn, UK).  The in-solution digest of bovine 
serum albumin (CAM-modified) was purchased from New England BioLabs (Hitchin, UK).  All 
other reagents with the exception of ClCCA were purchased from Sigma (Poole, UK).  ClCCA 
was synthesised by reacting malononitrile with 4-chlorobenzaldehyde in pyridine in the presence 
of piperidine (5 mol%).  After 1 hour at 50°C the solvents were removed under reduced pressure.  
The remaining residue was acidified (1M hydrochloric acid) and then extracted with ethyl 
acetate.  The ethyl acetate was dried (magnesium sulfate), filtered and then concentrated in 
vacuo.  The resulting colourless solid was assessed by 
1
H NMR and re-crystallised from hot 
ethanol until no signals that were not associated with the structure of the product were 
discernable giving a final impurity of less than 0.5%. 
Instrumentation for MALDI-TOF MS 
MALDI measurements were performed using an Ultraflex axial-TOF mass spectrometer (Bruker 
Daltonics, Bremen, Germany) using FlexControl 3.0 acquisition software.  Positive ion 
measurements were taken in reflectron mode using a nitrogen laser (337 nm) with an 
acceleration voltage of 25 kV and a delayed ion extraction setting of 40 ns.  For all experiments, 
384-well MTP 400μm-AnchorChip target plates were used (Bruker Daltonics). 
MALDI sample preparation 
Analyte preparation 
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Unless otherwise stated the analytes used were prepared in 50% MeOH / 0.05% TFA at a 
concentration to yield the final reported on-target amount after matrix and analyte premixing.  
The analyte composition of the individual analyte solutions used for each experiment can be 
found in the relevant subsections. 
Solid state MALDI 
Both the CHCA and ClCCA crystalline matrices for solid state MALDI were prepared at 3 
mg/ml in acetone and diluted to a final concentration of 0.5 mg/ml in acetone:ethanol (1:4; v/v).  
In all cases the matrix solution was mixed with the analyte solution in a ratio of 2:1(v/v), and 1.5 
µL of this mixture was deposited on the MALDI target.  To increase MALDI sample 
homogeneity and concentration, the crystalline MALDI samples were re-crystallized on-target 
with 0.5 µL ethanol:acetone:0.1% trifluoroacetic acid (TFA) (6:3:1; v/v/v). 
Liquid MALDI 
The liquid matrices were prepared as follows.  The CHCA-containing LSM was prepared by 
dissolving CHCA and 3-AQ in solution A (aqueous 10 mM ammonium phosphate (AP) 50% 
methanol solution) and glycerol in a ratio of approximately 1:3:5:5 (w/w/v/v) with 1 mg equating 
to 1 µL and then diluted by a factor of 30 with solution A. The ClCCA-containing LSM was 
prepared by dissolving ClCCA and 3-AQ in solution A and glycerol in a ratio of approximately 
1:5:10:5 (w/w/v/v) and diluted by a factor of 20 with solution A.  The CHCA-containing ILM 
was prepared by dissolving CHCA and 3-AQ in methanol in a ratio of 1:3:5 (w/w/v) and diluted 
by a factor of 30 with 50% methanol / 0.1% octyl β-D-glucopyranoside (OGP) with AP, which 
was adjusted to a final concentration of 5 mM.  Finally, the ClCCA-containing ILM was 
prepared by dissolving ClCCA and 3-AQ in methanol in a ratio of 1:5:10 (w/w/v) and diluted by 
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a factor of 20 with 50% methanol with AP, which was adjusted to a final concentration of 5 mM.  
In all cases the initial stock solutions were sonicated until full dissolution occurred prior to the 
final dilution step.  The stock solutions could be kept for several days at 4°C.  For analysis the 
matrices were premixed 1:1 with analyte solution and a volume of 1 µL was deposited on the 
MALDI target. 
MALDI-TOF analysis 
MALDI imaging 
The homogeneity of the MALDI sample preparation for each of the matrices was assessed by 
MALDI imaging.  The on-target sample amounts were 100 fmol Bradykinin 1-7, 100 fmol 
Angiotensin I and 300 fmol ACTH clip 18-39.  Custom geometry files (.xeo files) for 
FlexControl defining sampling positions were created using our in-house-written software and 
loaded by substituting the geometry file relating to the type of target plate used.  The positions 
were sampled automatically using the AutoXecute function in FlexControl.  An over-sampling 
technique was used by setting sample positions 25 µm apart (laser focus: ~50 µm).  Spectra were 
acquired by data accumulation from a total of 10 laser pulses at each position.  The resulting 
spectral files were combined and the peak intensity for a user defined mass (+/- 1Da-window) for 
each position was exported to Microsoft Excel™ using another in-house-written program. 
Signal stability 
To assess the signal stability and longevity of the liquid matrices 100 spectra were acquired from 
a central position of a liquid droplet containing 100 fmol of Angiotensin I.  Each spectrum was 
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acquired as the sum of 100 single-shot spectra at 50 Hz with a gap of ~1 sec between each 
acquisition, resulting in a total of 10,000 individual exposures on a single position. 
Quantitation 
The ability of the ClCCA-containing LSM to perform quantitation without the need of an 
internal standard via the linear relationship between analyte amount present and signal response 
was assessed across a dynamic range of 5 – 1000 fmol (of each analyte) spotted on target using 
an equimolar mixture of 7 peptides.  The mixture consisted of RFDS (m/z 524.25), Bradykinin 
(m/z 757.40), Angiotensin I (m/z 1296.68), Substance P (m/z 1347.74), Glu-Fibrinopeptide B 
(m/z 1570.68), ACTH (II) clip 18-39 (m/z 2465.20) and Somatostatin 28 (m/z 3147.47) (m/z 
values refer to monoisotopic protonated species).  The peptide solutions were prepared in 50% 
MeOH / 0.05% TFA and premixed 1:1 with matrix with 1 µL spotted to give final on-target 
amounts of 5, 10, 50, 100, 250, 500 and 1000 fmols of each of the peptides.  Four replicates of 
each dilution were spotted and 700 single-shot spectra were acquired from a single central 
position of which the last 500 were accumulated.  The first 200 spectra were discarded to avoid 
any initial surface concentration effect as previously described.
24
  The R
2
 values were calculated 
from the average of the four spots. 
PMM analysis 
The BSA in-solution digest was dissolved in 50% methanol / 0.05% TFA for normal analysis or 
with 25mM ammonium bicarbonate (ABC) 50% MeOH / 0.05% TFA for an assessment of how 
the matrices respond to contamination with a commonly used buffering agent.  The analyte was 
diluted for final on-target amounts of 100, 10 and 1 fmol with 1 µL of matrix/analyte mixture 
deposited for the liquid matrices and 1.5µL for the solid state matrices.  A sum of five 100shot-
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acquisitions was used for each analysis.  Spectra were calibrated externally using a standard 
calibration mixture of nine peptides covering an m/z range of 524-3658.  For the crystalline 
matrices, spectra were acquired by sampling multiple positions and selecting only those positions 
that gave a superior response in terms of the number of putative peptide signals, signal intensity, 
and resolution for the final summed spectra.  In contrast, for the liquid matrices the spectra were 
acquired from a single central position only.  Peak picking was performed with FlexAnalysis 2.4 
using the SNAP (sophisticated numerical annotation procedure) algorithm.  Peaks were picked 
between m/z 800-4000 with a maximum of 150 peaks and a signal-to-noise threshold of 4 (2 for 
1fmol-samples).  PMM analysis was performed using Mascot (Matrix Science Ltd., London, 
UK) against all entries in the Swiss-Prot database version 57.10 with a mass tolerance of 100 
ppm, up to 3 missed cleavages, a fixed modification of cysteines by carbamidomethylation and a 
variable modification of methionine oxidation.  In addition, a 250 attomol sample was analysed 
for the ClCCA-containing ILM.  This was performed by diluting the BSA digest to 1 fmol/µL 
and then mixing it in a ratio of 1:2 with matrix solution prior to spotting out 0.75 µL resulting in 
250 attomol of BSA on target.  Spectra from a total of 1000 laser pulses were acquired for each 
of 4 replicates.  Assignments were made using Biotools 3.1 (Bruker Daltonics) against the BSA 
sequence as listed in the Swiss-Prot database (P02769). 
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RESULTS AND DISCUSSION 
Matrix Characteristics 
The newly created ClCCA liquid matrices have very similar appearances to the previously 
reported CHCA-containing LSM.
3, 12
  In the diluted form, the liquid matrices appear as a clear 
yellow liquid.  After mixing with the analyte solution and deposition on the target, volatile 
solvent evaporation occurs.  This results in the formation of a small, viscous, clear yellow, 
vacuum-stable matrix droplet, approximately 400-500 µm in diameter (Figure 1).  The apparent 
viscosity of the droplet varies between the preparations, with the CHCA ILM appearing to show 
the highest degree of viscosity, followed by the ClCCA ILM preparation and then the two LSMs.  
The use of the 400μm-AnchorChip target was deemed to be preferable as the hydrophilic anchor 
aids in the localisation of the liquid matrix droplets as they shrink to cover the anchor.  Spotting 
directly on to a hydrophobic portion of the target plate, which did not contain an anchor, results 
in the formation of a spot of similar size and dimensions.  However, the final position of the spot 
is more variable.  In general, at least for the matrices presented here, any smooth and/or 
hydrophobic surface can be utilised and for example, data has been published utilising polished 
stainless steel
30
 and Teflon™ tape.24 Attempts to use brushed stainless steel resulted in the 
formation of a thin film as the matrix droplet diameter did not reduce. 
 The CHCA-containing ILM has a tendency to form a thin film which appears to be less 
favourable for MS measurements as positions can easily become depleted of matrix forming a 
hole within the film rather than self-healing of the film.  The addition of OGP was found to 
alleviate this problem promoting droplet formation.  Increasing the level of OGP up to 0.1% 
within the diluted matrix resulted in a progressive alteration in the droplet appearance from thin 
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film to droplet formation (see Supplemental Data 1).  Further increases of the level of OGP cause 
a disruption of the droplet’s surface tension, which results in the formation of several smaller 
droplets of varying sizes.  The exact nature of these effects has not been investigated. 
AP can be added to all of the liquid matrices in order to avoid the presence of matrix clusters 
within the mass range of interest and reduce the formation of adduct peaks (mainly due to 
sodium and potassium)
3, 35, 36
  For the CHCA-containing LSM without the addition of AP intense 
matrix cluster peaks are observed at m/z 855, 1060 and 1066.  With the addition of AP at a 
concentration of 0.5 mM within the diluted matrix preparation these can be completely 
suppressed.  This, however, is not sufficient to suppress adduct ion formation within the LSMs.  
It was found that the glycerol-based LSMs required an increased concentration of AP in 
comparison to the ILMs (10 mM versus 5 mM) in order to suppress adduct ion formation.  The 
ILMs with the inclusion of AP have a very similar degree of adduct formation and matrix 
background in comparison to the solid state matrices.  Unfortunately, the elevated low-mass 
matrix background signals below 650 Da seen within the LSMs are higher than those seen for the 
other matrices.  However, this is below the mass range important for the performance of PMM 
experiments.  It was also noted that further increasing the concentration of AP, resulted in a 
higher laser energy threshold for analyte ion detection for the glycerol-based LSMs but no 
significant further gains in terms of adduct suppression were observed.  Without the addition of 
AP the laser energy thresholds for LSMs were similar to the ILMs.  The apparent laser energy 
thresholds for analyte ion detection can be roughly summarized as follows: CHCA-solid state 
and CHCA-ILM < ClCCA-solid state and ClCCA-ILM < CHCA-LSM < ClCCA-LSM. 
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Initial stock solutions remained viable for up to one week if stored at 4°C.  When deposited on 
the target the matrix droplets were useable without significant loss of sensitivity for at least 24 
hours with or without being under vacuum, although it should be noted that when removed from 
the vacuum the ClCCA-containing liquid matrices became cloudy and solidified taking on a 
paste-like consistency within one hour.  The CHCA-containing liquid matrices seemed to remain 
liquid for at least 5 days on the target after initial analysis but matrix performance degraded and 
the matrices turned to a dark brown colour. 
14 
 
 
Figure 1.  Liquid MALDI samples after evaporation of the volatile solvents.  Top left, CHCA-
containing glycerol LSM.  Top right, CHCA-containing ILM.  Bottom left, ClCCA-containing 
glycerol LSM.  Bottom right, ClCCA-containing ILM.  Sample appearance was unchanged after 
exposure to the vacuum.  Each spot/droplet has a diameter of ~400 µm. 
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Homogeneity 
Considering the tendency of crystalline matrices to form inhomogeneous analyte-matrix 
distributions, which can complicate analysis, the liquid matrices with their superior homogeneity 
can be highly desirable.  In order to examine the analyte distributions various solid state and 
liquid matrices were analysed by MALDI imaging.  Figure 2 shows the results of these analyses 
for the peptides Bradykinin 1-7, Angiotensin I, and ACTH clip 18-39.  It can be seen that the 
liquid matrices, particularly the LSMs, have a much simpler analyte distribution in comparison 
to the crystalline matrices.  The crystalline matrices (Figure 2a/b) have several pronounced “hot 
spots” displaying a complex distribution, which is different for each peptide.  The MALDI 
images of the liquid matrices show less “hot spots” and a smoother analyte ion signal distribution 
(Figure 2c-f) somewhat reflecting the three-dimensional shape of the droplet and the incidence 
angle of the laser beam.  The comparison of the distributions of the three analytes also shows that 
the liquid matrices enable a relatively similar analyte distribution in contrast to the differential, 
analyte-dependent ion signal distribution observable in crystalline matrices.  However, it can be 
observed that the ILM samples (Figure 2d and f) show a slightly decreased homogeneity 
compared to the LSM samples.  The reason for this is unclear but could be attributable to the 
process of solvent evaporation.  It can be observed that as the ILM samples undergo the final 
stages of solvent evaporation two distinct domains form, an outer domain and an inner domain.  
The inner domain, which is slightly lighter in coloration, reduces in size until it is no longer 
apparent.  It is possible that the slight decrease in homogeneity is due to a varying degree of 
concentration of some analytes within this inner domain.  This is not observed for the LSM 
samples, possibly due to the glycerol support aiding in the homogeneity of the matrices by 
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allowing all components to remain evenly distributed during the volatile solvent evaporation 
process. 
17 
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Figure 2.  MALDI analyte ion signal distribution studied by MS imaging for the crystalline 
matrices CHCA (A) and ClCCA (B) and the liquid matrices CHCA-containing LSM (C), 
CHCA-containing ILM (D), ClCCA-containing LSM (E), and ClCCA-containing ILM (F).  The 
distributions of the analytes Bradykinin 1-7 (left column; 100 fmol spotted), Angiotensin I 
(middle column; 100 fmol spotted) and ACTH 18-39 (right column; 300 fmol spotted) can be 
seen.  The images were taken with a 25µm-raster (laser focus: ~50 µm).  A total of 10 single-
shot spectra at 50 Hz were recorded for each MS imaging point.  The images are normalised 
against the maximum intensity obtained.  Each image displays an irradiated area of 825 µm x 
825 µm. 
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Continuous single position sampling 
One key advantage of liquid MALDI is the ability to sample from a single position for extended 
periods of time or number of laser pulses without extensive ion signal fluctuation or loss of ion 
signal.  This has advantages for techniques such as MS/MS or instrument tuning as a prolonged 
stable ion signal is desirable
24
.  Figure 3 shows the stability of ion production for the peptide 
Angiotensin I (100 fmol spotted) over the course of 10,000 laser pulses recorded as a series of 
100 spectra, each the summation of 100 single-shot spectra for each of the liquid matrices.  The 
CHCA-containing liquid matrices (Figure 3a) appeared to possess greater stability in comparison 
to the ClCCA-containing liquid matrices (Figure 3b) with only a slight gradual decrease in signal 
intensity of ~25% over 10,000 laser pulses.  Despite the ClCCA-containing LSM being less 
stable across the 10,000 laser pulses it maintained ion signal intensity.  The ClCCA-containing 
ILM showed a less stable ion signal, decreasing by 61.7% after 5,000 laser pulses.  However, the 
signal-to-noise ratio only fell by 35.3% to 493.3.  This matrix may benefit from a lower laser 
pulse repetition rate as unlike the other liquid matrices, a localized distortion of the spot’s hemi-
spherical appearance was observed along with a minor darkening of the exposed area which 
could be due to inferior droplet renewal at the high laser pulse repetition rate of 50 Hz.  In 
comparison, the ion signal was depleted within 1,000 laser pulses when continuously sampling a 
single position with either of the crystalline matrices.  The ion signal could be extended for the 
crystalline matrices by rastering across the surface.  However, the signal stability would be 
affected by the crystal morphology and the sample homogeneity at each position as has been 
previously shown
24
 and can be seen in Figure 2a/b.  Although thin-layer sample preparations can 
to some extent alleviate the problem of sample inhomogeneity, this is typically achieved at the 
expense of faster overall sample depletion, particularly when compared with liquid MALDI 
20 
 
samples.
21 
 
 
 
Figure 3.  Ion signal intensity of the [M+H]
+
 of Angiotensin I with an increasing number of laser 
pulses.  Spectra were acquired as the sum of 100 single-shot spectra at 50 Hz from a single 
desorption position with ~1 sec between each accumulation, for a total of 10,000 laser pulses.  
Panel A, CHCA-containing LSM (solid line), CHCA-containing ILM (dotted line). Panel B, 
ClCCA-containing LSM (solid line), ClCCA-containing ILM (dotted line). 
22 
 
Quantitation 
Stable ion flux also facilitates quantitative analysis.  Quantitive analysis of peptides using liquid 
matrices has previously been demonstrated with a linear dynamic range of up to 3 orders of 
magnitude and extremely high R
2
 value for the CHCA-containing LSM.
24
  Consequently, the 
ability to perform quantitation was also assessed for the ClCCA-containing LSM using an equal 
mixture of 7 peptides (m/z 524-2465) with a dynamic range of 5 fmol – 1 pmol.  The average R2 
value for the 7 peptides was 0.98 with three peptides having an R
2
 value of greater than 0.99 
(Figure 4).  
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Figure 4.  Ion signal intensity as a function of sample amount (5 – 1000 fmol spotted) for the 
ClCCA-containing LSM.  Four spots were measured for each data point (500 laser pulses each).  
Data are shown for Angiotensin I (diamonds), Substance P (squares) and Glu-Fibrinopeptide B 
(circles).  All R
2
 values are greater than 0.99. 
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Peptide mass mapping 
Previous analyses of tryptic BSA digests have shown that both ClCCA as crystalline matrix and 
the utilisation of liquid matrices lead to an increased sequence coverage.
3, 33, 37
  We have 
investigated whether the same effect can be observed with the newly created ClCCA liquid 
matrices and whether the use of ClCCA will give a further increase over the CHCA-based liquid 
matrices.  Table 1 shows the results of Mascot searches on spectra generated using 100, 10 and 1 
fmol of a BSA in-solution digest for the crystalline and liquid matrices.  Example spectra for 
each matrix at 100 fmol can be seen in Figure 5.  The spectra shown in Figure 5 were selected as 
those that were closest to resembling the average displayed in Table 1 and are the result of the 
summation of 500 single-shot spectra.  At an analyte level of 100 fmol all of the liquid matrices 
showed an increase in performance compared to the CHCA crystalline matrix.  The ClCCA-
containing ILM was relatively similar to the ClCCA crystalline matrix, with higher sequence 
coverage but a lower average number of matching peaks.  At 10 fmol the performance of the 
ClCCA-containing ILM and ClCCA crystalline matrix was again similar while the other liquid 
matrices were roughly equal in performance to the CHCA crystalline matrix.  With 1 fmol on 
target the ClCCA crystalline and ClCCA-containing ILM preparations outperformed the other 
matrices with the ClCCA-containing ILM showing a higher sequence coverage and higher 
number of matched peaks, as well as a higher MASCOT score when compared with its 
crystalline counterpart (Table 1). 
The lower sequence coverage of the LSM samples compared to the ILM samples is possibly 
related to an effect of surface activity with some peptides being present at a lower concentration 
at the surface.  Alternatively, the LSM samples may have a higher overall homogeneity with the 
peptides within the ILMs being concentrated to a higher degree at the surface, thereby increasing 
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the sensitivity.  In either case the surface homogeneity, as investigated in Figure 2, is less 
affected and thus, further studies, for instance of the internal spatial distribution of the analyte 
and matrix components within the droplet, are necessary. However, it should be noted that in 
previous studies it has been found that for a liquid matrix comprising of diethanolamine and 
CHCA, surface partitioning is severely suppressed in comparison to aqueous systems.
38-40
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Table 1 – Results of Mascot searches for the analysis of 100, 10, and 1 fmol on-target amounts of 
BSA in-solution digest (averaged over 5 replicates for each matrix, 4 replicates for 1 fmol of 
analyte).  Peaks were picked between m/z 800-4000 with a signal-to-noise ratio ≥ 4 (≥ 2 for 1 
fmol). 
 
Matrix # of 
picked 
peaks 
sequence 
coverage 
[%] 
# of matched 
peaks ± SD 
Mascot score 
(sig ≥ 70) ± SD 
100 fmol     
     
ClCCA 142 79.4 58 ± 4 317.4 ± 32.8 
ClCCA ILM 150 82.4 53 ± 1 269.4 ± 9.2 
ClCCA LSM 150 75.4 49 ± 2 237.8 ± 14.8 
CHCA 112 70.4 44 ± 5 241.2 ± 25.9 
CHCA ILM 133 75.0 48 ± 5 256.4 ± 27.2 
CHCA LSM 150 75.2 51 ± 2 248.0 ± 17.0 
     
10 fmol     
     
ClCCA 105 74.8 49 ± 2 305.0 ± 15.9 
ClCCA ILM 112 72.8 48 ± 3 288.6 ± 13.1 
ClCCA LSM 87 54.8 35 ± 3 210.6 ± 26.3 
CHCA 79 57.2 32 ± 3 181.0 ± 27.6 
CHCA ILM 77 60.2 37 ± 5 251.6 ± 32.7 
CHCA LSM 84 53.8 33 ± 2 182.8 ± 6.1 
     
1 fmol     
     
ClCCA 70 41.3 24 ± 1 129.5 ± 21.0 
ClCCA ILM 54 46.0 28 ± 2 199.0 ± 21.2 
ClCCA LSM 28 26.3 13 ± 2 93.0 ± 21.2 
CHCA 75 23.3 12 ± 3 32.5 ± 7.5 
CHCA ILM 20 29.5 15 ± 5 148.3 ± 23.6 
CHCA LSM 27 25.3 15 ± 1 115.0 ± 11.0 
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Figure 5.  Example mass spectra of an in-solution BSA digest with 100 fmol spotted on target for 
(A) crystalline ClCCA matrix, (B) ClCCA-containing ILM, (C) ClCCA-containing LSM, (D) 
crystalline CHCA matrix, (E) CHCA-containing ILM and (F) CHCA-containing LSM.  A total 
of 500 single-shot spectra were acquired per spectrum.  Tick-marks denote peaks matching 
theoretical BSA tryptic digest masses.  * denotes expanded peak. 
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It has previously been reported that the enhanced peptide recovery seen with solid state ClCCA-
containing MALDI samples in comparison to solid state CHCA-containing samples is 
attributable to an increase in the observable number of small and/or acidic peptides.
34
  In light of 
this the isoelectric point (IEP) values have been calculated for  the tryptic BSA peptides 
identified in the various Mascot searches, as well as all those peptides which could have been 
theoretically observed based on the parameters used.  This was performed using the ProtParam 
tool allowing for up to three missed cleavages and without consideration of post-translational 
modifications (http://www.expasy.org/tools/protparam.html).  Interestingly, it was found that the 
average percentage of peptides matched with all matrices, which had an IEP < 7, was much 
higher than expected when compared to the percentage make up of all possibly matched peptides 
(~81-85% for the 100 fmol samples compared to 63% for the theoretical dataset).  Similarly, the 
percentage of small peptides (<1500 Da) was also raised (~34-41% compared to 23%).  
Examining the average number of peaks matched with the BSA digest at a level of 100 fmol, it 
can be seen that all LMs and the solid state ClCCA-containing samples show an increase in the 
number of acidic peptides and small peptides when compared to the solid state CHCA-
containing samples whilst the number of basic peptides and peptides above 1500 Da (with the 
exception of the solid state ClCCA-containing samples) do not increase significantly.  The 
average number of peptides above 1500 Da is increased for the solid state ClCCA samples when 
compared to the solid state CHCA samples (38 ± 3.8 compared to 29 ± 2.5).  At the 10 fmol 
level only the solid state ClCCA samples and ClCCA ILM samples show a significant increase 
in the average number of acidic peptides compared the solid state CHCA samples (40.6 ± 1.5 and 
39.2 ± 2.2 compared to 27.2 ± 2.2) with all showing an increase in small peptides compared to 
solid state CHCA samples.  At 1fmol however, the increases seen for the solid state ClCCA 
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samples and ClCCA ILM samples are approximately twofold for both large/small and 
acidic/basic peptides.  It can be seen therefore that the data for the 100 and 10fmol-BSA digests 
concurs with the data which was previously reported by Jaskolla et al. 
34
 for the solid state 
ClCCA samples, and the same effect can be seen for the ClCCA ILM samples.  However, the 
increases at the lower analyte level (1 fmol) appear to be of general nature.  The lists of peptides 
matched in the various classes can be seen in Supplementary Data 2. 
The CHCA-containing LSM has been reported to be superior in the analysis of biological 
samples of limited purity
3
 and to have a high tolerance for contaminants and commonly used 
buffers such as ABC.
27
  In a second set of experiments the PMM analysis with 100 fmol of BSA 
was repeated in the presence of ABC at 25 mM within the analyte solution.  The results of this 
analysis can be seen in Table 2.  In the presence of ABC, both crystalline matrices showed 
disturbed crystallisation even after re-crystallisation.  Both ILMs showed evidence of an 
internalised cloudy sub-surface region occupying approximately one quarter of the surface area.  
Sampling of this region revealed that it was void of ion signal and so was avoided during data 
acquisition.   In contrast the appearance of the LSMs did not alter.  From the comparison of the 
data in Table 1 and 2 it can be seen that the presence of ABC had no negative effect on the 
performance of these matrices, which concurs with the previously reported data for the CHCA-
containing LSM.
3, 27
 Despite the overall lower performance of the LSMs compared to the ILMs 
seen in Table 1, the inclusion of glycerol can be seen to be beneficial in some cases by adding an 
increased level of robustness to the matrix preparations and ion signal stability. 
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Table 2 – Results of Mascot searches for the analysis of 100 fmol on-target amount of BSA in-
solution digest in the presence of 25 mM ammonium bicarbonate (averaged over 5 replicates for 
each matrix).  Peaks were picked between m/z 800-4000 with a signal-to-noise ratio ≥ 4. 
 
Matrix # of picked 
peaks 
sequence 
coverage [%] 
# of matched 
peaks ± SD 
Mascot score 
(sig ≥ 70) ± SD 
ClCCA 78 53.8 32 ± 9 190.2 ± 57.5 
ClCCA ILM 150 68.3 43 ± 2 187.8 ± 24.1 
ClCCA LSM 150 76.4 50 ± 3 230.6 ± 23.6 
CHCA  147 42.7 24 ± 13 (99.0/177.0)
a
 
CHCA ILM 135 45.0 31 ± 1 100.4 ± 5.5 
CHCA LSM 149 72.4 48 ± 2 222.6 ± 13.6 
 
a 
Only 2 of 5 search results reported significant hits. 
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Of the liquid matrices investigated here the ClCCA-containing ILM can be seen to have provided 
the highest levels of sequence coverage and peptide recovery at the lowest levels of analyte 
present.  Recently, Jaskolla et al. have shown that ClCCA as crystalline matrix facilitates the 
analysis of attomol quantities of analyte present on the target.
41
  Similar observations were made 
with the ClCCA-containing ILM.  An average of 8 ± 1.4 matching peptides obtained from 4 
replicates was observed, giving an average sequence coverage of 17.5 ± 3.6%.  Despite the 
somewhat lower sequence coverage compared to the previously reported coverage for ClCCA as 
crystalline matrix, it represents a significant improvement in relation to both the CHCA LSM 
and solid state CHCA matrix.  Due to the nature of the linear correlation between the 
concentration of analyte within a liquid matrix and the analyte response, it may be possible to 
improve this result further via a careful reduction in the matrix droplet size.  Attempts to do this 
via greater matrix dilutions proved unsatisfactory, due to a concomitant higher concentration of 
contaminants within the shrunk droplet, leading to increased matrix adduct formation and 
general background noise.  A method such as that described by Tu et al (2008)
42
 for the precise 
deposition of a small quantity of diluted matrix solution may be preferable.
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CONCLUSION 
The data presented here shows that the novel ClCCA liquid matrices display similar 
characteristics to the previously reported CHCA liquid matrices.  The glycerol-based LSMs 
show a particularly high homogeneity with a simple analyte distribution pattern, predominately 
independent of the peptide that is chosen as analyte, thus simplifying greatly the data acquisition.  
Although not quite as homogenous as the LSMs, the ILMs also show an improved analyte 
distribution and sample morphology in comparison to their crystalline counterparts.  The 
investigated liquid matrices demonstrate a high degree of stability over a large number of 
measurements, allowing at least 10,000 laser pulses from a single position, and thus making 
them ideal for techniques such as MS/MS where a large number of spectra need to be acquired.  
This high degree of stability along with the high homogeneity enables quantitation to be 
performed without the need for an internal standard. 
It can be seen from PMM analyses of a BSA digest that the investigated liquid matrices clearly 
outperform the crystalline CHCA matrix at the higher peptide concentrations (100 fmol) and at 
the very least show comparable results at the lower concentrations (10 and 1 fmol).  The recently 
introduced ClCCA crystalline matrix again proves its superiority over the classical CHCA 
matrix.  However, the novel ClCCA-containing ILM, as prepared and evaluated in this study, 
appears to be at least equally sensitive to its crystalline counterpart with somewhat better PMM 
performance at the 1fmol-level.  Interestingly, the glycerol-based LSMs consistently 
outperformed all other matrices once the sample purity was deteriorated by adding 25 mM ABC. 
From this data it can be concluded that the ClCCA-containing ILM represents a distinct 
improvement in terms of sensitivity compared to the other liquid matrices tested, and that it can 
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be seen as a viable alternative to its crystalline counterpart combining the desirable properties of 
a liquid matrix with the high sensitivity of the newly introduced ClCCA matrix compound.
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FIGURE LEGENDS 
 
Figure 1.  Liquid MALDI samples after evaporation of the volatile solvents.  Top left, CHCA-
containing glycerol LSM.  Top right, CHCA-containing ILM.  Bottom left, ClCCA-containing 
glycerol LSM.  Bottom right, ClCCA-containing ILM.  Sample appearance was unchanged after 
exposure to the vacuum.  Each spot/droplet has a diameter of ~400 µm. 
 
Figure 2.  MALDI analyte ion signal distribution studied by MS imaging for the crystalline 
matrices CHCA (A) and ClCCA (B) and the liquid matrices CHCA-containing LSM (C), 
CHCA-containing ILM (D), ClCCA-containing LSM (E), and ClCCA-containing ILM (F).  The 
distributions of the analytes Bradykinin 1-7 (left column; 100 fmol spotted), Angiotensin I 
(middle column; 100 fmol spotted) and ACTH 18-39 (right column; 300 fmol spotted) can be 
seen.  The images were taken with a 25µm-raster (laser focus: ~50 µm).  A total of 10 single-
shot spectra at 50 Hz were recorded for each MS imaging point.  The images are normalised 
against the maximum intensity obtained.  Each image displays an irradiated area of 825 µm x 
825 µm. 
 
Figure 3.  Ion signal intensity of the [M+H]
+
 of Angiotensin I with an increasing number of laser 
pulses.  Spectra were acquired as the sum of 100 single-shot spectra at 50 Hz from a single 
desorption position with ~1 sec between each accumulation, for a total of 10,000 laser pulses.  
Panel A, CHCA-containing LSM (solid line), CHCA-containing ILM (dotted line). Panel B, 
ClCCA-containing LSM (solid line), ClCCA-containing ILM (dotted line). 
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Figure 4.  Ion signal intensity as a function of sample amount (5 – 1000 fmol spotted) for the 
ClCCA-containing LSM.  Four spots were measured for each data point (500 laser pulses each).  
Data are shown for Angiotensin I (diamonds), Substance P (squares) and Glu-Fibrinopeptide B 
(circles).  All R
2
 values are greater than 0.99. 
 
Figure 5.  Example mass spectra of an in-solution BSA digest with 100 fmol spotted on target for 
(A) crystalline ClCCA matrix, (B) ClCCA-containing ILM, (C) ClCCA-containing LSM, (D) 
crystalline CHCA matrix, (E) CHCA-containing ILM and (F) CHCA-containing LSM.  A total 
of 500 single-shot spectra were acquired per spectrum.  Tick-marks denote peaks matching 
theoretical BSA tryptic digest masses.  * denotes expanded peak. 
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TOC graphic and synopsis 
 
 
The 4-chloro-α-cyanocinnamic acid (ClCCA) ionic liquid matrix (ILM) and liquid support 
matrix (LSM) show an improved sample morphology and homogeneity for UV-MALDI MS.  In 
comparison to the crystalline ClCCA (and α-cyano-4-hydroxycinnamic acid), these matrices 
possess highly stable and durable analyte signal, allowing for quantitation over 3 orders of 
magnitude without an internal standard.  In addition both ILM and LSM show an increase in 
performance and sensitivity for peptide mass mapping. 
 
